Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-wg55d Total loading time: 0 Render date: 2024-06-08T15:32:19.606Z Has data issue: false hasContentIssue false

Chapter 3 - Principles of Geriatric Pharmacotherapy

Published online by Cambridge University Press:  13 October 2018

By
John W. Devlin  and
Jeffrey F. Barletta
Edited by
Shamsuddin Akhtar  and
Stanley Rosenbaum
Shamsuddin Akhtar
Affiliation:
Yale University School of Medicine
Stanley Rosenbaum
Affiliation:
Yale University School of Medicine
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Principles of Geriatric Critical Care , pp. 28 - 50
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Fuchs, L, Chronaki, CE, Park, S, et al. ICU admission characteristics and mortality rates among elderly and very elderly patients. Intensive Care Med 2012; 38(10):1654–61.CrossRefGoogle ScholarPubMed
Balas, MC, Devlin, JW, Verceles, AC, et al. Adapting the ABCDEF bundle to meet the needs of patients requiring prolonged mechanical ventilation in the long-term acute care hospital setting: historical perspectives and practical implications. Semin Respir Crit Care Med 2016; 37(1):119–35.Google ScholarPubMed
Cullen, DJ, Sweitzer, BJ, Bates, DW, et al. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med 1997; 25:1289–97.CrossRefGoogle ScholarPubMed
Scales, DC, Fisher, HD, Li, P, et al. Unintentional continuation of medications intended for acute illness after hospital discharge: a population-based cohort study. J Gen Intern Med 2015; 31:196–202.CrossRefGoogle Scholar
Bell, CM, Brener, SS, Gunraj, N, et al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA 2011; 306:840–47.CrossRefGoogle ScholarPubMed
Budnitz, DS, Pollock, DA, Weidenbach, KN, et al. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006; 296(15):1858–66.CrossRefGoogle ScholarPubMed
Jolivot, PA, Hindlet, P, Pichereau, C, et al. A systematic review of adult admissions to ICUs related to adverse drug events. Crit Care 2014; 18(6):643.CrossRefGoogle ScholarPubMed
Qato, DM, Wilder, J, Schumm, LP, et al. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs. 2011. JAMA Intern Med 2016; 176(4):473–82.CrossRefGoogle ScholarPubMed
Devlin, JW, Barletta, JF Principles of drug dosing in the critically ill. In Parillo, JW, Dellinger, RP, eds., Critical Care Medicine: Principles of Diagnosis and Management in the Adult (3rd edn). Philadelphia, PA: Mosby-Elsevier, 2008: 343–76.Google Scholar
Lat, I, Micek, S, Janzen, J, et al. Off-label medication use in adult critical care patients. J Crit Care 2011; 26:89–94.CrossRefGoogle ScholarPubMed
American Geriatrics Society. Beers Criteria Update Expert Panel: American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2015; 63:2227–46.Google Scholar
Morandi, A, Vasilevskis, EE, Pandharipande, PP, et al. Inappropriate medications in elderly ICU survivors: where to intervene? Arch Intern Med 2011; 171(11):1032–34.CrossRefGoogle ScholarPubMed
Floroff, CK, Slattum, PW, Harpe, SE, et al. Potentially inappropriate medication use is associated with clinical outcomes in critically ill elderly patients with neurological injury. Neurocrit Care 2014; 21(3):526–33.CrossRefGoogle ScholarPubMed
Morandi, A, Vasilevskis, E, Pandharipande, PP, et al. Inappropriate medication prescriptions in elderly adults surviving an intensive care unit hospitalizations. J Am Geriatr Soc 2013; 61:1128–34.CrossRefGoogle Scholar
Needham, DM, Davidson, J, Cohen, H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders’ conference. Crit Care Med 2012; 40(2):502–9.CrossRefGoogle ScholarPubMed
Stollings, JL, Bloom, SL, Huggins, EL, et al. Medication management to ameliorate post–intensive care syndrome. AACN Adv Crit Care 2016; 27(2):133–40.Google ScholarPubMed
Klotz, U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 2009; 41(2):67–76.CrossRefGoogle ScholarPubMed
Pisani, MA Considerations in caring for the critically ill older patient. J Intensive Care Med 2009; 24(2):83–95.CrossRefGoogle ScholarPubMed
Cusack, BJ Pharmacokinetics in older persons. Am J Geriatr Pharmacother 2004; 2(4):274–302.CrossRefGoogle ScholarPubMed
Mühlberg, W, Platt, D. Age-dependent changes of the kidneys: pharmacological implications. Gerontology 1999; 45(5):243–53.CrossRefGoogle ScholarPubMed
Oskvig, RM Special problems in the elderly. Chest 1999; 115(Suppl 5):S158S–64.CrossRefGoogle ScholarPubMed
Turnheim, K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003; 38(8):843–53.CrossRefGoogle ScholarPubMed
Akhtar, S, Ramani, R. Geriatric pharmacology. Anesthesiol Clin 2015; 33(3):457–69.CrossRefGoogle ScholarPubMed
Bowie, MW, Slattum, PW Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother 2007; 5(3):263–303.CrossRefGoogle ScholarPubMed
ElDesoky, ES Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther 2007; 14(5):488–98.CrossRefGoogle ScholarPubMed
Naples, JG, Hanlon, JT, Schmade, KE, et al. Recent literature on medication errors and adverse events in older adults. J Am Geriatr Soc 2016; 64(2):401–8.CrossRefGoogle ScholarPubMed
Nebeker, JR, Barach, P, Samore, MH Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med 2004; 140(10):795–801.CrossRefGoogle ScholarPubMed
Cook, RI, Render, M, Woods, DD Gaps in the continuity of care and progress on patient safety. BMJ 2000; 320:791–94.CrossRefGoogle ScholarPubMed
Nasraway, SA Jr, Albert, M, Donnelly, AM, et al. Morbid obesity is an independent determinant of death among surgical critically ill patients. Crit Care Med 2006; 34(4):964–70.CrossRefGoogle ScholarPubMed
Erstad, BL Dosing of medications in morbidly obese patients in the intensive care unit setting. Intensive Care Med 2004; 30(1):18–32.CrossRefGoogle ScholarPubMed
Alobaid, AS, Hites, M, Lipman, J, et al. Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: a structured review. Int J Antimicrob Agents 2016; 47(4):259–68.CrossRefGoogle ScholarPubMed
de Mendonça, A, Vincent, JL, Suter, PM, et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000; 26(7):915–21.Google ScholarPubMed
Winter, MA, Guhr, KN, Berg, GM Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation. Pharmacotherapy 2012; 32(7):604–12.CrossRefGoogle ScholarPubMed
Wilhelm, SM, Kale-Pradhan, PB Estimating creatinine clearance: a meta-analysis. Pharmacotherapy 2011; 31(7):658–64.CrossRefGoogle ScholarPubMed
Scoville, BA, Mueller, BA Medication dosing in critically ill patients with acute kidney injury treated with renal replacement therapy. Am J Kidney Dis 2013; 61(3):490–500.CrossRefGoogle ScholarPubMed
Heintz, BH, Matzke, GR, Dager, WE Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Pharmacotherapy 2009; 29(5):562–77.CrossRefGoogle ScholarPubMed
Aronoff, GR, Bennett, WM, Berns, JS, et al. Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children (5th edn). Philadelphia, PA: American College of Physicians, 2007.Google Scholar
Vilay, AM, Churchwell, MD, Mueller, BA Clinical review: drug metabolism and nonrenal clearance in acute kidney injury. Crit Care 2008; 12(6):235.CrossRefGoogle ScholarPubMed
Lewis, SJ, Mueller, BA Antibiotic dosing in patients with acute kidney injury: “enough but not too much.” J Intensive Care Med 2016; 31(3):164–76.CrossRefGoogle Scholar
Halilovic, J, Heintz, BH Antibiotic dosing in cirrhosis. Am J Health Syst Pharm 2014; 71(19):1621–34.CrossRefGoogle ScholarPubMed
Verbeeck, RK Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol 2008; 64(12):1147–61.CrossRefGoogle ScholarPubMed
Barr, J, Fraser, GL, Puntillo, K, et al. Clinical practice guidelines for the management of pain, agitation and delirium in adult ICU patients. Crit Care Med 2013; 41(1):263–30.CrossRefGoogle ScholarPubMed
Devlin, JW, Fraser, GL, Riker, RR Drug-induced coma and delirium. In Papadopoulos, J, Cooper, B, Kane-Gill, S, Mallow-Corbett, S, Barletta, J, eds., Drug-Induced Complications in the Critically Ill Patient: A Guide for Recognition and Treatment (1st edn). Chicago, IL: Society of Critical Care Medicine, 2011.Google Scholar
Balas, MC, Vasilevskis, EE, Olsen, KM, et al. Effectiveness and safety of the awakening and breathing coordination, delirium monitoring/management, and early exercise/mobility bundle. Crit Care Med 2014; 42:1024–36.CrossRefGoogle ScholarPubMed
Devlin, JW, Mallow-Corbett, S, Riker, RR Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med 2010; 38(Suppl 6):S231–43.CrossRefGoogle ScholarPubMed
Devlin, JW, Roberts, RJ Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids. Anesthesiol Clin 2011; 29(4):567–85.CrossRefGoogle ScholarPubMed
Fraser, GL, Devlin, JW, Worby, CP, et al.Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Crit Care Med. 2013; 41(9; Suppl 1):S30–38.CrossRefGoogle ScholarPubMed
Pandharipande, PP, Shintani, A, Peterson, J, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006; 104(1):21–26.CrossRefGoogle ScholarPubMed
Zaal, IJ, Devlin, JW, Hazelbag, M, et al. Benzodiazepine-associated delirium in critically ill adults. Intensive Care Med 2015; 41:2130–37.CrossRefGoogle ScholarPubMed
Ely, EW, Shintani, A, Truman, B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004; 291:1753–62.CrossRefGoogle ScholarPubMed
Salluh, JI, Wang, H, Scheider, EB, et al. Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ 2015; 350:H2538.CrossRefGoogle ScholarPubMed
Neufeld, KJ, Yue, J, Robinson, TN, et al. Antipsychotic medication for prevention and treatment of delirium in hospitalized adults: a systematic review and meta-analysis. J Am Geriatr Soc 2016; 64(4):705–14.CrossRefGoogle ScholarPubMed
Serafim, RB, Bozza, FA, Soares, M, et al. Pharmacologic prevention and treatment of delirium in intensive care patients: a systematic review. J Crit Care 2015; 30:799–807.CrossRefGoogle ScholarPubMed
Trogrlić, Z, van der Jagt, M, Bakker, J, et al. A systematic review of implementation strategies for assessment, prevention, and management of ICU delirium and their effect on clinical outcomes. Crit Care 2015; 19:157.CrossRefGoogle ScholarPubMed
Schreiber, MP, Colantuoni, E, Bienvenu, OJ, et al. Corticosteroids and transition to delirium in patients with acute lung injury. Crit Care Med 2014; 42(6):1480–86.CrossRefGoogle ScholarPubMed
Wolters, AE, Veldhuizjzen, DS, Zaal, IJ, et al. Systemic corticosteroids and transition to delirium in critically ill patients. Crit Care Med 2015; 43(12):e585–88.CrossRefGoogle ScholarPubMed
Wolters, AE, Zaal, IJ, Veldhuijzen, DS, et al. Anticholinergic medication use and transition to delirium in critically ill patients: a prospective cohort study. Crit Care Med 2015; 43(9):1846–52.CrossRefGoogle ScholarPubMed
Marshall, J, Herzig, SJ, Howell, MD, et al. Antipsychotic utilization in the intensive care unit and in transitions of care. J Crit Care 2016; 33:119–24.CrossRefGoogle ScholarPubMed
Rowe, AS, Hamilton, LA, Curtis, RA, et al. Risk factors for discharge on a new antipsychotic medication after admission to an intensive care unit. J Crit Care 2015; 30:1283–86.CrossRefGoogle Scholar
Page, VJ, Ely, EW, Gates, S, et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 2013; 1:515–23.CrossRefGoogle ScholarPubMed
Al-Qadheeb, NS, Skrobik, Y, Schumaker, G, et al. Preventing ICU subsyndromal delirium conversion to delirium with low-dose IV haloperidol: a double-blind, placebo-controlled, pilot study. Crit Care Med 2016; 583–91.CrossRefGoogle ScholarPubMed
Reade, MC, Eastwood, GM, Bellomo, R, et al. Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: a randomized clinical trial. JAMA 2016; 315:1460–68.CrossRefGoogle ScholarPubMed
Pisani, MA, Friese, RS, Gehlbach, BK, et al. Sleep in the intensive care unit. Am J Respir Crit Care Med 2015; 191:731–38.CrossRefGoogle ScholarPubMed
Arixtra [package insert]. GlaxoSmithKline, Research Triangle Park, NC, August 2009.Google Scholar
Romanelli, RJ, Nolting, L, Dolginsky, M, et al. Dabigatran versus warfarin for atrial fibrillation in real-world clinical practice: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 2016; 9(2):126–34.CrossRefGoogle ScholarPubMed
Abraham, NS, Singh, S, Alexander, GC, et al. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. BMJ 2015; 350:H1857.CrossRefGoogle ScholarPubMed
Ivascu, FA, Howells, GA, Junn, FS, et al. Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality. J Trauma 2005; 59(5):1131–37.Google ScholarPubMed
Frontera, JA, Lewin, JJ 3rd, Rabinstein, AA, et al. Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care 2016; 24(1):6–46.CrossRefGoogle ScholarPubMed
Pollack, CV Jr, Reilly, PA, Eikelboom, J, et al. Idarucizumab for dabigatran reversal. N Engl J Med 2015; 373(6):511–20.CrossRefGoogle ScholarPubMed
Gallegos-Orozco, JF, Foxx-Orenstein, AE, Sterler, SM, et al. Chronic constipation in the elderly. Am J Gastroenterol 2012; 107(1):18–25.CrossRefGoogle ScholarPubMed
Harari, D, Gurwitz, JH, Avorn, J, et al. Constipation: assessment and management in an institutionalized elderly population. J Am Geriatr Soc 1994; 42(9):947–52.CrossRefGoogle Scholar
Wald, A. Constipation: advances in diagnosis and treatment. JAMA 2016; 315(2):185–91.Google ScholarPubMed
Patanwala, AE, Abarca, J, Huckleberry, Y, et al. Pharmacologic management of constipation in the critically ill patient. Pharmacotherapy 2006; 26(7):896–902.CrossRefGoogle ScholarPubMed
Barletta, JF, Kanji, S, MacLaren, R, et al. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada. J Crit Care 2014; 29(6):955–60.CrossRefGoogle ScholarPubMed
Barletta, JF, Sclar, DA Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences. Pharmacoeconomics 2014; 32(1):5–13CrossRefGoogle ScholarPubMed
Barletta, JF, El-Ibiary, SY, Davis, LE, et al. Proton pump inhibitors and the risk for hospital-acquired Clostridium difficile infection. Mayo Clin Proc 2013; 88(10):1085–90.CrossRefGoogle ScholarPubMed
MacLaren, R, Reynolds, PM, Allen, RR Histamine-2 receptor antagonists vs. proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med 2014; 174(4):564–74.CrossRefGoogle ScholarPubMed
Gomm, W, von Holt, K, Thomé, F, et al. Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurol 2016; 73(4):410–16.CrossRefGoogle ScholarPubMed
Lazarus, B, Chen, Y, Wilson, FP Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 2016; 176(2):238–46.Google ScholarPubMed
Maggio, M, Corsonello, A, Ceda, GP, et al. Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals. JAMA Intern Med 2013; 173(7):518–23.CrossRefGoogle ScholarPubMed
American Diabetes Association. Older Adults. Diabetes Care 2016; 39(Suppl 1):S81–85.CrossRefGoogle Scholar
Carpenter, DL, Gregg, SR, Xu, K, et al. Prevalence and impact of unknown diabetes in the ICU. Crit Care Med 2015; 43(12):e541–50.CrossRefGoogle ScholarPubMed
American Diabetes Association. Diabetes care in the hospital. Diabetes Care 2016; 39(Suppl 1):S99–104.CrossRefGoogle Scholar
Moghissi, ES, Korytkowski, MT, DiNardo, M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009; 32(6):1119–31.CrossRefGoogle Scholar
Jacobi, J, Bircher, N, Krinsley, J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012; 40(12):3251–76.CrossRefGoogle ScholarPubMed
Krinsley, JS, Grover, A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007; 35(10):2262–67.CrossRefGoogle ScholarPubMed
Magill, SS, Edwards, JR, Beldavs, ZG, et al. Prevalence of antimicrobial use in US acute care hospitals, May–September 2011. JAMA 2014; 312(14):1438–46.CrossRefGoogle ScholarPubMed
Roberts, JA, Ulldemolins, M, Roberts, MS, et al. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept. Int J Antimicrob Agents 2010; 36(4):332–39.CrossRefGoogle ScholarPubMed
Roberts, JA, Paul, SK, Akova, M, et al. DALI: defining antibiotic levels in intensive care unit patients. Are current β-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 2014; 58(8):1072–83.CrossRefGoogle ScholarPubMed
Taccone, FS, Laterre, PF, Dugernier, T, et al. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care 2010; 14(4):R126.CrossRefGoogle ScholarPubMed
Lodise, TP, Drusano, GL, Zasowski, E, et al. Vancomycin exposure in patients with methicillin-resistant Staphylococcus aureus bloodstream infections: how much is enough? Clin Infect Dis 2014; 59(5):666–75.CrossRefGoogle Scholar
Lewin, JJ, Devlin, JW Critical care pharmacy practice. In University of the Sciences in Philadelphia, ed., Remington: The Science and Practice of Pharmacy (22nd edn). Philadelphia, PA: University of the Sciences in Philadelphia, 2012.Google Scholar
Society of Critical Care Medicine. ICU liberation campaign, 2016, available at www.iculiberation.org (accessed May 28, 2016).Google Scholar
Preslaski, CR, Lat, I, MacLaren, R, et al. Pharmacist contributions as members of the multidisciplinary ICU team. Chest 2013; 144(5):1687–95.CrossRefGoogle ScholarPubMed
Hume, AL, Kirwin, J, Bieber, HL, et al., for the American College of Clinical Pharmacy. Improving care transitions: current practice and future opportunities for pharmacists. Pharmacotherapy 2012; 32(11):e326–37.Google ScholarPubMed
Scott, IA, Hilmer, SN, Reeve, E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA 2015; 11:852–57.Google Scholar
Varkey, P, Cunningham, J, O’Meara, J, et al. Multidisciplinary approach to inpatient medication reconciliation in an academic setting. Am J Health Syst Pharm 2007; 64:850–54.CrossRefGoogle Scholar
Rodehover, C, Fearing, D. Medication reconciliation in acute care: ensuring an accurate drug regimen on admission and discharge. Jt Comm J Qual Patient Saf 2005; 31:406–13.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×